Breast cancer drug approved for NHS use after price cut

Breast cancer drug approved for NHS use after price cut Perjeta can help shrink breast cancer tumours before patients undergo surgery to remove them.

A drug that can help shrink breast cancer tumours before patients undergo surgery to remove them has been approved for use in the NHS, after the manufacturer agreed a substantial discount on the list price.

Perjeta, the brand name of pertuzumab, could be helpful in the treatment of 1,400 women a year who develop a particularly aggressive form of breast cancer, but it was initially turned down by Nice, the National Institute for Healthcare Excellence, because of the high price set by the manufacturer, Roche Continue reading... The Guardian